Impact of Real-world Off-label dose of Apixaban on long-term clinical outcomes in Atrial Fibrillation patients with Heart failure and Chronic Kidney Disease

Back

EHRA Premium Access

Impact of Real-world Off-label dose of Apixaban on long-term clinical outcomes in Atrial Fibrillation patients with Heart failure and Chronic Kidney Disease

Session: Poster session 3: clinical management of arrhythmias

Topic: Oral Anticoagulation

Speaker: Doctor S. Im (Pusan, KR)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Sung Il Im

kosin university gospel hospital, Pusan (Korea (Republic of))

0 follower

151 more presentations in this session

The relationship between left atrial electroanatomical voltage mapping and CMR-based fibrosis for enhanced preplanning in atrial fibrillation ablation

Speaker: Doctor Z. Dadon (Jerusalem, IL)

Cardiac sympathetic denervation for different cardiovascular indications - the experience of two referral centers

Speaker: Doctor A. Zienciuk-Krajka (Gdansk, PL)

Access

Abstract

Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation

Speaker: Doctor J. Simic (Belgrade, RS)

Risk of left atrial thrombus in patients undergoing catheter ablation for atrial fibrillation and atrial flutter

Speaker: Assistant Professor F. Guerra (Ancona, IT)

Clustering analysis of left atrial smax patterns: predicting atrial fibrillation termination and associations with key clinical factors

Speaker: Mr J. Huh (Seoul, KR)

Access

Abstract

Slides

Access the full session

Poster session 3: clinical management of arrhythmias

Speakers: Doctor S. Im, Doctor Z. Dadon, Doctor A. Zienciuk-Krajka, Doctor J. Simic, Assistant Professor F. Guerra...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources